ADMA Biologics Inc (ADMA) earnings · P/E 22, rev $238.9M
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
This ADMA earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ADMA revenue for 2026-06-30 was $238.9M. Net income was $83.2M. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
When the next ADMA 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for ADMA. We will not invent a beat or miss.
Not investment advice. Full ADMA research stays on the stock page; the tape stays on the quote page.
Not investment advice.